IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population

Detalhes bibliográficos
Autor(a) principal: Cavalcante, Lourianne N.
Data de Publicação: 2012
Outros Autores: Abe Sandes, Kiyoko, Angelo, Ana Luiza Dias, Machado, Taisa Manuela Bonfim, Lemaire, Denise Carneiro, Mendes, Carlos Maurício Cardeal, Pinho, João Renato Rebello, Malta, Fernanda, Lyra, Luiz Guilherme Costa, Lyra, André Castro
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFBA
Texto Completo: http://repositorio.ufba.br/ri/handle/ri/15681
Resumo: Texto completo: acesso restrito. p. 476–486
id UFBA-2_08f4fa85b9ce06743d1dc5a3dd66c4bc
oai_identifier_str oai:repositorio.ufba.br:ri/15681
network_acronym_str UFBA-2
network_name_str Repositório Institucional da UFBA
repository_id_str 1932
spelling Cavalcante, Lourianne N.Abe Sandes, KiyokoAngelo, Ana Luiza DiasMachado, Taisa Manuela BonfimLemaire, Denise CarneiroMendes, Carlos Maurício CardealPinho, João Renato RebelloMalta, FernandaLyra, Luiz Guilherme CostaLyra, André CastroCavalcante, Lourianne N.Abe Sandes, KiyokoAngelo, Ana Luiza DiasMachado, Taisa Manuela BonfimLemaire, Denise CarneiroMendes, Carlos Maurício CardealPinho, João Renato RebelloMalta, FernandaLyra, Luiz Guilherme CostaLyra, André Castro2014-08-22T14:49:14Z20121478-3223http://repositorio.ufba.br/ri/handle/ri/15681v. 32, n. 3Texto completo: acesso restrito. p. 476–486Background IL28B polymorphisms are predictors of therapy response in hepatitis C virus (HCV) patients. We do not know whether they are markers of treatment response in admixed populations or not. Aims To determine whether IL28B polymorphisms are predictors of therapy response in patients with HCV from an admixed population and are influenced by genetic ancestry. Methods rs12979860 and rs8099917 were genotyped in 222 HCV patients treated with pegylated interferon and ribavirin. Ancestry was determined using genetic markers. Results IL28B rs12979860 C/C was associated with sustained virological response (SVR), whereas C/T and T/T were associated with failure to therapy (P = 1.12 × 10−5). IL28B rs8099917 T/T was associated with SVR, and G/G and G/T were associated with nonresponse/relapse (NR/R) (P = 8.00 × 10−3). Among HCV genotype 1 patients with C/C genotype, genomic ancestry did not interfere with therapy response. Among patients with rs12979860 T/T genotype, African genetic contribution was greater in the NR/R group (P = 1.51 × 10−3), whereas Amerindian and European genetic ancestry contribution were higher in the SVR group (P = 3.77 × 10−3 and P = 2.16 × 10−2 respectively). Among HCV type 1 patients with rs8099917 T/T, African genetic contribution was significantly greater in the NR/R group (P = 5.0 × 10−3); Amerindian and European ancestry genetic contribution were greater in the SVR group. Conclusion IL28B rs12979860 and rs8099917 polymorphisms were predictors of therapy response in HCV genotypes 1, 2 and 3 subjects from an admixed population. Genomic ancestry did not interfere with response to therapy in patients with rs12979860 C/C, whereas it interfered in patients with C/T and T/T genotypes. Among HCV genotype 1 rs8099917 T/T patients, genomic ancestry interfered with response to therapy.Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-08-19T13:40:07Z No. of bitstreams: 1 Lourianne N. Cavalcante.pdf: 230836 bytes, checksum: 6a5af776161023563ae193168f44a8c2 (MD5)Approved for entry into archive by Delba Rosa (delba@ufba.br) on 2014-08-22T14:49:14Z (GMT) No. of bitstreams: 1 Lourianne N. Cavalcante.pdf: 230836 bytes, checksum: 6a5af776161023563ae193168f44a8c2 (MD5)Made available in DSpace on 2014-08-22T14:49:14Z (GMT). No. of bitstreams: 1 Lourianne N. Cavalcante.pdf: 230836 bytes, checksum: 6a5af776161023563ae193168f44a8c2 (MD5) Previous issue date: 2012http://dx.doi.org/ 10.1111/j.1478-3231.2011.02653.xreponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAAntiviral therapyGenetic ancestryHepatitis CIL28BPolymorphismSingle nucleotideIL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed populationLiver Internationalinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10000-01-01info:eu-repo/semantics/openAccessengORIGINALLourianne N. Cavalcante.pdfLourianne N. Cavalcante.pdfapplication/pdf230836https://repositorio.ufba.br/bitstream/ri/15681/1/Lourianne%20N.%20Cavalcante.pdf6a5af776161023563ae193168f44a8c2MD51LICENSElicense.txtlicense.txttext/plain1345https://repositorio.ufba.br/bitstream/ri/15681/2/license.txtff6eaa8b858ea317fded99f125f5fcd0MD52TEXTLourianne N. Cavalcante.pdf.txtLourianne N. Cavalcante.pdf.txtExtracted texttext/plain46368https://repositorio.ufba.br/bitstream/ri/15681/3/Lourianne%20N.%20Cavalcante.pdf.txt188905ccaabf12e7253a6cd9802906f3MD53ri/156812022-08-08 13:17:45.749oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-08-08T16:17:45Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false
dc.title.pt_BR.fl_str_mv IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
dc.title.alternative.pt_BR.fl_str_mv Liver International
title IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
spellingShingle IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
Cavalcante, Lourianne N.
Antiviral therapy
Genetic ancestry
Hepatitis C
IL28B
Polymorphism
Single nucleotide
title_short IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
title_full IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
title_fullStr IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
title_full_unstemmed IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
title_sort IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
author Cavalcante, Lourianne N.
author_facet Cavalcante, Lourianne N.
Abe Sandes, Kiyoko
Angelo, Ana Luiza Dias
Machado, Taisa Manuela Bonfim
Lemaire, Denise Carneiro
Mendes, Carlos Maurício Cardeal
Pinho, João Renato Rebello
Malta, Fernanda
Lyra, Luiz Guilherme Costa
Lyra, André Castro
author_role author
author2 Abe Sandes, Kiyoko
Angelo, Ana Luiza Dias
Machado, Taisa Manuela Bonfim
Lemaire, Denise Carneiro
Mendes, Carlos Maurício Cardeal
Pinho, João Renato Rebello
Malta, Fernanda
Lyra, Luiz Guilherme Costa
Lyra, André Castro
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cavalcante, Lourianne N.
Abe Sandes, Kiyoko
Angelo, Ana Luiza Dias
Machado, Taisa Manuela Bonfim
Lemaire, Denise Carneiro
Mendes, Carlos Maurício Cardeal
Pinho, João Renato Rebello
Malta, Fernanda
Lyra, Luiz Guilherme Costa
Lyra, André Castro
Cavalcante, Lourianne N.
Abe Sandes, Kiyoko
Angelo, Ana Luiza Dias
Machado, Taisa Manuela Bonfim
Lemaire, Denise Carneiro
Mendes, Carlos Maurício Cardeal
Pinho, João Renato Rebello
Malta, Fernanda
Lyra, Luiz Guilherme Costa
Lyra, André Castro
dc.subject.por.fl_str_mv Antiviral therapy
Genetic ancestry
Hepatitis C
IL28B
Polymorphism
Single nucleotide
topic Antiviral therapy
Genetic ancestry
Hepatitis C
IL28B
Polymorphism
Single nucleotide
description Texto completo: acesso restrito. p. 476–486
publishDate 2012
dc.date.issued.fl_str_mv 2012
dc.date.accessioned.fl_str_mv 2014-08-22T14:49:14Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufba.br/ri/handle/ri/15681
dc.identifier.issn.none.fl_str_mv 1478-3223
dc.identifier.number.pt_BR.fl_str_mv v. 32, n. 3
identifier_str_mv 1478-3223
v. 32, n. 3
url http://repositorio.ufba.br/ri/handle/ri/15681
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.pt_BR.fl_str_mv http://dx.doi.org/ 10.1111/j.1478-3231.2011.02653.x
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFBA
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Repositório Institucional da UFBA
collection Repositório Institucional da UFBA
bitstream.url.fl_str_mv https://repositorio.ufba.br/bitstream/ri/15681/1/Lourianne%20N.%20Cavalcante.pdf
https://repositorio.ufba.br/bitstream/ri/15681/2/license.txt
https://repositorio.ufba.br/bitstream/ri/15681/3/Lourianne%20N.%20Cavalcante.pdf.txt
bitstream.checksum.fl_str_mv 6a5af776161023563ae193168f44a8c2
ff6eaa8b858ea317fded99f125f5fcd0
188905ccaabf12e7253a6cd9802906f3
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv
_version_ 1808459484614361088